Skip Navigation

Division of Population Sciences Centers

  • The four core centers and programs that comprise the Division of Population Sciences are: the Division of Cancer Genetics and Prevention; the Center for Outcomes and Policy Research; the Center for Community-Based Research; and the Translational Informatics Group.

    Division of Cancer Genetics and Prevention

    Cancer Genetics and Prevention Research Program

    Judy Garber, MD, MPH
    Judy Garber, MD, MPH

    Investigators in the Division of Cancer Genetics and Prevention, led by Judy Garber, MD, MPH, are focused on understanding the role of germline mutations in contributing to cancer risk, prognosis, and response to treatment. Researchers have pioneered ways to identify and treat patients with BRCA-associated breast cancer, Lynch syndrome-associated colorectal cancer, Li Fraumeni Syndrome, as well as many other familial cancer syndromes. Key research relates to the development of strategies to identify families with inherited cancer susceptibility and ways to help them to mitigate risk. An emerging set of projects evaluates treatment strategies that are tailored to the distinct biology of cancers that arise in the setting of germline mutations. Researchers collaborate with local, national, and international investigators and lead large multi-site collaborations aimed at decreasing the burden of cancer driven by heritable risk.

    Cancer Genetics and Prevention Clinical Program

    The Division of Cancer Genetics and Prevention includes a remarkable team of medical and surgical oncologists, gastroenterologists, geneticists, genetic counselors, gynecologists, and nurses who provide leading edge cancer risk assessment and comprehensive recommendations for managing cancer risk. We partner with clinicians from diverse specialties, offering cancer risk assessment, genetic counseling and testing, and continuing educational resources in the complex and dynamic field of cancer genetics.

    We work in collaboration with patients and their providers to offer our expertise in the assessment and management of all forms of inherited cancer syndromes. In addition, our team is prepared to assist with the introduction of newer genetic testing methods and the germline aspects of personalized cancer medicine.

    Judy E. Garber, MD, MPH
    Susan F. Smith Chair, Dana-Farber Cancer Institute
    Professor of Medicine, Harvard Medical School
    Chief, Division of Cancer Genetics and Prevention

    Sapna Syngal, MD, MPH
    Professor of Medicine, Harvard Medical School
    Director, Gastrointestinal Cancer Genetics and Prevention Clinic
    Director of Research, Division of Genetics and Prevention, Gastrointestinal Cancer

    Ramona Lim, MD
    Instructor in Medicine, Harvard Medical School

    Timothy Rebbeck, PhD
    Vincent L. Gregory, Jr. Professor of Cancer Prevention
    Director, Zhu Family Center for Global Cancer Prevention
    Professor of Cancer Epidemiology, Harvard T.H. Chan School of Public Health  

    Huma Q. Rana, MD
    Assistant Professor of Medicine, Harvard Medical School
    Clinical Director, Division of Cancer Genetics and Prevention

    Matthew B. Yurgelun, MD
    Assistant Professor of Medicine, Harvard Medical School

    Learn more about the Division of Cancer Genetics and Prevention

    Center for Outcomes and Policy Research

    Deborah Schrag, MD, MPH
    Deborah Schrag, MD, MPH

    Researchers at the Division of Population Science's Center for Outcomes and Policy Research, founded in 1995 by Jane Weeks, MD, MSc, and led by Deborah Schrag, MD, MPH, aim to enhance the outcomes of interventions to prevent and treat cancer from both efficacy and cost-effectiveness perspectives. Investigations focus on optimizing the patient experience by ensuring that clinical and societal resources from interventions to services are utilized in the best possible way. By identifying determinants of the quality of care patients receive, investigators can work toward eliminating barriers to optimal care and translate their findings and programs on a large scale.

    Deborah Schrag, MD, MPH
    Professor of Medicine, Harvard Medical School
    Chief, Division of Population Sciences, Department of Medical Oncology

    Gregory A. Abel, MD, MPH
    Associate Professor of Medicine, Harvard Medical School

    Kira Bona, MD, MPH
    Assistant Professor of Pediatrics, Harvard Medical School

    Andrea Enzinger, MD
    Assistant Professor in Medicine, Harvard Medical School

    Andrew Hantel, MD
    Instructor, Dana-Farber Cancer Institute

    Jennifer C. Kesselheim, MD, MEd, MBE
    Associate Professor of Pediatrics, Harvard Medical School

    Christopher Lathan, MD, MS, MPH
    Assistant Professor of Medicine, Harvard Medical School

    Jennifer W. Mack, MD, MPH
    Associate Professor of Pediatrics, Harvard Medical School

    Catherine Marinac, PhD
    Member of Faculty, Dana-Farber Cancer Institute

    Oreofe Odejide, MD, MPH
    Assistant Professor of Medicine, Harvard Medical School

    Rinaa S. Punglia, MD, MPH
    Associate Professor of Radiation Oncology, Harvard Medical School

    Shoshana Rosenberg, ScD, MPH
    Assistant Professor of Medicine, Harvard Medical School

    Alexi Wright, MD, MPH
    Assistant Professor of Medicine, Harvard Medical School

    Hajime Uno, PhD
    Assistant Professor of Medicine, Harvard Medical School

    Center for Community-Based Research

    Glorian Sorensen, PhD, MPH
    Glorian Sorensen, PhD, MPH

    The mission of the Center for Community-Based Research, led by Glorian Sorensen, PhD, MPH, is to address and reduce cancer risk and mitigate cancer disparities through community-based and communication research and translation of research findings in the United States and globally. The Center aims to achieve these goals through documenting social and behavioral determinants of cancer risk, developing and testing interventions to reduce cancer risk, and studying their dissemination and implementation to maximize effective translation to influence policy and practice. The Center conducts research across the cancer control continuum, e.g., methods development, efficacy and effectiveness testing, implementation and dissemination research. The Center’s cancer prevention and control research focus includes the following core priorities:

    • Generate evidence on social and behavioral determinants of cancer risk
    • Translate evidence into effective cancer prevention interventions, communications, and policies
    • Disseminate evidence-based approaches to reduce cancer-related health disparities

    Glorian C. Sorensen, PhD, MPH
    Professor, Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health
    Director, Center for Community-Based Research

    K. "Vish" Viswanath, PhD
    Lee Kum Kee Professor of Health Communication, Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health
    Director, Health Communication Core, DF/HCC  

    Andy Tan, PhD, MPH, MBA, MBBS
    Assistant Professor, Harvard T.H. Chan School of Public Health, Department of Social and Behavioral Sciences

    Learn more about the Center for Community-Based Research.

    Learn about the research partnership in cancer health disparities between Dana-Farber/Harvard Cancer Center and the University of Massachusetts/Boston.

    Translational Informatics Group (TIG)

    Researchers in the Translational Informatics Group (TIG) within the Division of Population Sciences aim to integrate large molecular, clinical, administrative, survey, and biometric datasets to drive biomarker discovery, treatment selection, and cancer care delivery strategies. Their work utilizes a range of analytic techniques from traditional statistics, machine learning, and natural language processing applied to heterogeneous sources of data to develop integrative models of therapeutic benefit, and to measure their impact in the context of rapid therapeutic innovation. The group’s overarching goal is to translate data into evidence that informs patient care and population health. Their research is highly interdisciplinary and includes close collaborations with clinicians, data scientists, informaticians, epidemiologists, and molecular biologists across Dana-Farber, Dana-Farber/Harvard Cancer Center, and beyond.

    Alexander Gusev, PhD
    Assistant Professor of Medicine, Harvard Medical School

    Michael Hassett, MD, MPH
    Assistant Professor of Medicine, Harvard Medical School

    Kenneth Kehl, MD, MPH 
    Instructor in Medicine, Harvard Medical School

    David Liu, MD, MPH, MS 
    Instructor in Medicine, Harvard Medical School